Literature DB >> 24482693

Diagnostic accuracy of interferon gamma-induced protein 10 for tuberculosis: a meta-analysis.

Shu-Jin Guo1, Liu-Qun Jia1, Qian-Jing Hu1, Hong-Yu Long1, Cai-Shuang Pang1, Fu-Qiang Wen1.   

Abstract

The diagnostic accuracy of tuberculosis (TB) remains a clinical challenge, and a number of studies have used the interferon gamma-induced protein 10 (IP-10) in the diagnosis of TB. The aim of the present meta-analysis was to determine the overall accuracy of IP-10 in the diagnosis of TB. A systematic review of studies published in English from Medline, Embase and Cochrane Library was conducted and the data concerning the accuracy of IP-10 in the diagnosis of TB were pooled. The methodological quality of each study was assessed by QUADAS (quality assessment for studies of diagnostic accuracy). Statistical analysis was performed by employing Meta-Disc 1.4 soft-ware and STATA. The overall test performance was summarized using receiver operating characteristic curves. 14 studies, based on 2075 subjects, met the inclusion criteria. The summary estimates for IP-10 in the diagnosis of TB were: sensitivity 0.73 (95% CI, 0.71-0.76), specificity 0.83 (95% CI, 0.81-0.86), positive likelihood ratio 7.08 (95% CI, 3.94-12.72), negative likelihood ratio 0.26 (95% CI, 0.20-0.35) and diagnostic odds ratio 29.50 (95% CI, 14.43-60.30), and the area under the curve was 0.88. Our findings suggest that IP-10 may improve the accuracy of TB diagnosis, while the results of IP-10 assays should be interpreted in parallel with conventional test results and other clinical findings.

Entities:  

Keywords:  Interferon gamma-induced protein 10 (IP-10); diagnostic; meta-analysis; tuberculosis

Year:  2014        PMID: 24482693      PMCID: PMC3902245     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  26 in total

Review 1.  New and improved tuberculosis diagnostics: evidence, policy, practice, and impact.

Authors:  Madhukar Pai; Jessica Minion; Karen Steingart; Andrew Ramsay
Journal:  Curr Opin Pulm Med       Date:  2010-05       Impact factor: 3.155

Review 2.  The immunobiology of interferon-gamma inducible protein 10 kD (IP-10): a novel, pleiotropic member of the C-X-C chemokine superfamily.

Authors:  L F Neville; G Mathiak; O Bagasra
Journal:  Cytokine Growth Factor Rev       Date:  1997-09       Impact factor: 7.638

3.  Use of tuberculin skin test, IFN-γ release assays and IFN-γ-induced protein-10 to identify children with TB infection.

Authors:  Mohammed A Yassin; Roberta Petrucci; Kefyalew T Garie; Greg Harper; Aklilo Teshome; Isabel Arbide; Girum Asnake; Habiba J Ahmed; Tadesse Mammo; Kedir Yesuf; Luis E Cuevas
Journal:  Eur Respir J       Date:  2012-09-20       Impact factor: 16.671

Review 4.  Tuberculosis.

Authors:  Stephen D Lawn; Alimuddin I Zumla
Journal:  Lancet       Date:  2011-03-21       Impact factor: 79.321

5.  IP-10 is an additional marker for tuberculosis (TB) detection in HIV-infected persons in a low-TB endemic country.

Authors:  Valentina Vanini; Elisa Petruccioli; Cristiana Gioia; Gilda Cuzzi; Nicoletta Orchi; Alessia Rianda; Lucia Alba; Maria Letizia Giancola; Aristide Conte; Vincenzo Schininà; Elisa Busi Rizzi; Enrico Girardi; Delia Goletti
Journal:  J Infect       Date:  2012-03-29       Impact factor: 6.072

6.  Role of biochemical tests in the diagnosis of exudative pleural effusions.

Authors:  Dilek Ernam; Figen Atalay; H Canan Hasanoglu; Ozgül Kaplan
Journal:  Clin Biochem       Date:  2005-01       Impact factor: 3.281

7.  Tuberculous pleural effusions.

Authors:  D M Epstein; L R Kline; S M Albelda; W T Miller
Journal:  Chest       Date:  1987-01       Impact factor: 9.410

8.  Evaluating the potential of IP-10 and MCP-2 as biomarkers for the diagnosis of tuberculosis.

Authors:  M Ruhwald; T Bodmer; C Maier; M Jepsen; M B Haaland; J Eugen-Olsen; P Ravn
Journal:  Eur Respir J       Date:  2008-08-06       Impact factor: 16.671

9.  Multiple cytokines are released when blood from patients with tuberculosis is stimulated with Mycobacterium tuberculosis antigens.

Authors:  Kathryn L Kellar; Jennifer Gehrke; Stephen E Weis; Aida Mahmutovic-Mayhew; Blachy Davila; Margan J Zajdowicz; Robin Scarborough; Philip A LoBue; Alfred A Lardizabal; Charles L Daley; Randall R Reves; John Bernardo; Brandon H Campbell; William C Whitworth; Gerald H Mazurek
Journal:  PLoS One       Date:  2011-11-21       Impact factor: 3.240

10.  Enhanced expression of interferon-inducible protein 10 associated with Th1 profiles of chemokine receptor in autoimmune pulmonary inflammation of MRL/lpr mice.

Authors:  Fumitaka Shiozawa; Tsuyoshi Kasama; Nobuyuki Yajima; Tsuyoshi Odai; Takeo Isozaki; Mizuho Matsunawa; Yoshiyuki Yoda; Masao Negishi; Hirotsugu Ide; Mitsuru Adachi
Journal:  Arthritis Res Ther       Date:  2003-11-19       Impact factor: 5.156

View more
  3 in total

1.  Immune-mediated inflammatory diseases differently affect IGRAs' accuracy for latent tuberculosis infection diagnosis in clinical practice.

Authors:  Irene Latorre; Sonia Mínguez; José-Manuel Carrascosa; Juan Naves; Raquel Villar-Hernández; Beatriz Muriel; Cristina Prat; Esther García-García; Irma Casas; Eugeni Domènech; Carlos Ferrándiz; Lourdes Mateo; Jose Domínguez
Journal:  PLoS One       Date:  2017-12-07       Impact factor: 3.240

2.  Plasma Profiles of Inflammatory Markers Associated With Active Tuberculosis in Antiretroviral Therapy-Naive Human Immunodeficiency Virus-Positive Individuals.

Authors:  Oskar Olsson; Per Björkman; Marianne Jansson; Taye Tolera Balcha; Daba Mulleta; Habtamu Yeba; Christine Valfridsson; Fredric Carlsson; Sten Skogmar
Journal:  Open Forum Infect Dis       Date:  2019-01-31       Impact factor: 3.835

3.  Accumulate evidence for IP-10 in diagnosing pulmonary tuberculosis.

Authors:  Xia Qiu; Tao Xiong; Xiaojuan Su; Yi Qu; Long Ge; Yan Yue; Yan Zeng; Wenxing Li; Peng Hu; Dezhi Mu
Journal:  BMC Infect Dis       Date:  2019-10-30       Impact factor: 3.090

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.